These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8400412)

  • 1. Arrhythmia models in the rat.
    Cheung PH; Pugsley MK; Walker MJ
    J Pharmacol Toxicol Methods; 1993 Aug; 29(4):179-84. PubMed ID: 8400412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic action of naloxone. Suppression of picrotoxin-induced cardiac arrhythmias in the rat.
    Lin CJ; Chen YT; Kuo JS; Lee AY
    Jpn Heart J; 1992 May; 33(3):365-72. PubMed ID: 1522693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of antiarrhythmic drugs on canine ventricular arrhythmia models].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):29-39. PubMed ID: 2656435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
    Matsuzaki T; Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Feb; 231(3):363-70. PubMed ID: 8449229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiarrhythmic effects of DHA-As on ventricular arrhythmias in rat and dog hearts].
    Xue Y; Aye NN; Hashimoto K
    Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():165P-170P. PubMed ID: 9503426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of the class 1c antiarrhythmic drug, flecainide, on canine ventricular arrhythmia models.
    Akiyama K; Hashimoto K
    Jpn Heart J; 1989 Jul; 30(4):487-95. PubMed ID: 2509760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tedisamil and lidocaine enhance each other's antiarrhythmic activity against ischaemia-induced arrhythmias in rats.
    Sarraf G; Barrett TD; Walker MJ
    Br J Pharmacol; 2003 Aug; 139(8):1389-98. PubMed ID: 12922925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
    Dupuis BA; Vincent AC
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor.
    Yahiro E; Ideishi M; Wang LX; Urata H; Kumagai K; Arakawa K; Saku K
    Cardiology; 2003; 99(2):61-7. PubMed ID: 12711879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic effects of a new drug, E-0747, on canine ventricular arrhythmia models.
    Mitsuhashi H; Akiyama K; Hashimoto K; Sawa Y; Hatori Y
    Jpn J Pharmacol; 1987 Jun; 44(2):155-62. PubMed ID: 3656773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms.
    Zhang Y; Liu Y; Wang T; Li B; Li H; Wang Z; Yang B
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1192-9. PubMed ID: 16406237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental evaluation of antiarrhythmic drugs efficacy.
    Schwartz PJ; Vanoli E; Zaza A; Zuanetti G
    Cardiologia; 1983 Sep; 28(9):747-65. PubMed ID: 6687331
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models.
    Hashimoto K; Sugiyama A; Haruno A; Matsuzaki T; Hirasawa A
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):336-42. PubMed ID: 1709241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute coronary artery occlusion-reperfusion-induced arrhythmias in rats, dogs and pigs: antiarrhythmic evaluation of quinidine, procainamide and lidocaine.
    Bergey JL; Nocella K; McCallum JD
    Eur J Pharmacol; 1982 Jul; 81(2):205-16. PubMed ID: 7117374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drugs. Treatment of cardiac arrhythmias.
    Muir WW
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):957-87. PubMed ID: 1949502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effect of magnesium sulfate against occlusion-induced arrhythmias and reperfusion-induced arrhythmias in anesthetized rats.
    Komori S; Li B; Matsumura K; Takusagawa M; Sano S; Kohno I; Osada M; Sawanobori T; Ishihara T; Umetani K; Ijiri H; Tamura K
    Mol Cell Biochem; 1999 Sep; 199(1-2):201-8. PubMed ID: 10544968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic actions of adenosine in the early stages of experimental myocardial ischaemia.
    Fagbemi O; Parratt JR
    Eur J Pharmacol; 1984 Apr; 100(2):243-4. PubMed ID: 6734719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.